These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 36103026)

  • 1. Cuproptosis identifies respiratory subtype of renal cancer that confers favorable prognosis.
    Li K; Tan L; Li Y; Lyu Y; Zheng X; Jiang H; Zhang X; Wen H; Feng C
    Apoptosis; 2022 Dec; 27(11-12):1004-1014. PubMed ID: 36103026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma.
    Wang B; Song Q; Wei Y; Wu X; Han T; Bu H; Tang S; Qian J; Shao P
    Front Immunol; 2022; 13():948042. PubMed ID: 36275737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma.
    Yuan H; Qin X; Wang J; Yang Q; Fan Y; Xu D
    Front Immunol; 2022; 13():971142. PubMed ID: 36131921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
    Bian Z; Fan R; Xie L
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma.
    Zhu M; Li Y; Wang Y; Lin P; Mi J; Zhong W
    Eur J Med Res; 2023 Jul; 28(1):248. PubMed ID: 37481601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated single-cell and bulk characterization of cuproptosis key regulator PDHB and association with tumor microenvironment infiltration in clear cell renal cell carcinoma.
    Wu J; Wang S; Liu Y; Zhang T; Wang X; Miao C
    Front Immunol; 2023; 14():1132661. PubMed ID: 37350959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenomedullin/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis.
    Wang X; Jia JH; Zhang M; Meng QS; Yan BW; Ma ZY; Wang DB
    FASEB J; 2023 Oct; 37(10):e23143. PubMed ID: 37698353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics pan-cancer study of cuproptosis core gene
    Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
    Front Immunol; 2022; 13():981764. PubMed ID: 36605188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer analysis of cuproptosis regulation patterns and identification of mTOR-target responder in clear cell renal cell carcinoma.
    Long S; Wang Y; Chen Y; Fang T; Yao Y; Fu K
    Biol Direct; 2022 Oct; 17(1):28. PubMed ID: 36209249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
    Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
    Front Immunol; 2022; 13():954440. PubMed ID: 36059510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma.
    Shen J; Wang L; Bi J
    BMC Cancer; 2023 Feb; 23(1):160. PubMed ID: 36797708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma.
    Wang H; Yang Z; He X; Guo F; Sun H; Xu S; Xu C; Wang Z; Wen H; Teng Z; Wang Y; Han Z
    BMC Cancer; 2023 Aug; 23(1):804. PubMed ID: 37641032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma.
    Tian X; Zhu S; Liu W; Wu X; Wei G; Zhang J; Anwaier A; Chen C; Ye S; Che X; Xu W; Qu Y; Zhang H; Ye D
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17451-17466. PubMed ID: 37889309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator
    Zeng S; Zhang H; Zhang D; Hu X; Song L
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment.
    Xie M; Cheng B; Yu S; He Y; Cao Y; Zhou T; Han K; Dai R; Wang R
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma.
    Lai SW; Weng PW; Yadav VK; Pikatan NW; Yeh CT; Hsieh MS; Chou CL
    Aging (Albany NY); 2024 Feb; 16(3):2679-2701. PubMed ID: 38305803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma.
    Liu H
    Cancer Genet; 2023 Jun; 274-275():21-25. PubMed ID: 36963335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.
    Xu S; Liu D; Chang T; Wen X; Ma S; Sun G; Wang L; Chen S; Xu Y; Zhang H
    Front Genet; 2022; 13():938259. PubMed ID: 35910212
    [No Abstract]   [Full Text] [Related]  

  • 19. Cuproptosis in ccRCC: key player in therapeutic and prognostic targets.
    Lv Y; Li Q; Yin L; He S; Qin C; Lu Z; Chen H
    Front Oncol; 2023; 13():1271864. PubMed ID: 37965478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma.
    Chu B; Hong Z; Zheng X
    Front Oncol; 2022; 12():925411. PubMed ID: 36212447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.